111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Mar '26 Dec '25 Sep '25 Jun '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.03 0.01 0.02 0.03
P/FCF ratio
0.00 2.75 0.00 0.00
P/Operating CF
(4.31) 4.95 7.35 (7.40)
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.02 (0.02) (0.01) 0.01
EV/EBITDA
0.00 112.75 11.29 0.00
EV/Operating CF
(3.16) (2.25) (3.55) 0.91
EV/FCF
(1.80) (4.73) 1.06 (5.29)
Quick Ratio
0.34 0.45 0.38 0.37
Current Ratio
1.08 1.09 1.07 1.13
Net Debt/EBITDA
6.96 1,147.50 169.59 (3,684.23)
Debt/Assets
13.32% 8.53% 6.85% 6.86%
Debt/Equity
(0.34) (0.26) (0.24) (0.25)
Asset Turnover
5.16 5.16 4.75 5.34
Operating CF/Net income
2.48 (1.79) (2.96) 3.07
Capex/Depreciation
— (0.37) — —
Interest Coverage
(2.54) (0.03) (0.32) 0.01
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.99% 2.84% 2.58% 2.61%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(2.10) (5.12) (2.83) (1.81)
Graham Number
19.85 16.33 14.65 14.50
Earnings Yield
(21.47%) (39.06%) (18.46%) (11.76%)
Free Cash Flow Yield
(36.12%) 36.37% (35.09%) (4.29%)
Revenue per Share
38.93 50.58 48.39 51.56
Operating CF per Share
(1.51) 0.52 0.62 (0.96)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(1.51) 0.52 0.62 (0.96)
Cash per Share
6.54 10.05 8.99 8.25
Shareholders Equity per Share
(12.51) (11.86) (11.36) (11.12)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(12.51) (11.86) (11.36) (11.12)
Free Cash Flow
(13.30) 4.50 5.39 (8.37)
Working Capital
20.81 24.48 22.72 36.89
Capital Expenditures
— (0.62) — —
Net Current Asset Value
(120.59) (113.95) (112.14) (111.88)
EV/EBIT
0.00 112.72 11.29 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
32.07 46.87 50.07 46.82
Average Payables
203.65 209.61 245.12 218.42
Average Inventory
166.20 166.43 197.24 183.28
Average Assets
319.93 348.28 390.21 364.76
Average Common Equity
(101.44) (96.67) (94.80) (91.12)

Fold the line items

Columns are period end dates